The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1759
July 20, 2026
View Complete Issue         Table of Contents 2019 
Drugs for Hypertriglyceridemia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Hypertriglyceridemia
July 20, 2026 (Issue: 1759)
Adults with persistent fasting triglyceride levels ≥150 mg/dL are considered to have hypertriglyceridemia; when levels are ≥500 mg/dL, it is considered severe. Hypertriglyceridemia is associated with an increased risk of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Hypertriglyceridemia
Article code: 1759e
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.